Aggressive Fibromatosis
6 clinical trials · Condition
◉ Watch Aggressive Fibromatosis
| Record | Firm | Date |
|---|---|---|
| Nirogacestat for Adults With Desmoid Tumor/Aggressive Fibromatosis (DT/AF) (NCT03785964) | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | 2019-04-17 |
| National Clinical-biological Prospective Cohort of Incident Cases of Aggressive Fibromatosis (ALTITUDES) (NCT02867033) | Centre Oscar Lambret | 2016-03-22 |
| Phase II Trial of the Gamma-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors/Aggressive Fibromatosis (NCT01981551) | National Cancer Institute (NCI) | 2013-10-31 |
| Study to Evaluate Imatinib in Desmoid Tumors (NCT01137916) | Heidelberg University | 2010-06-01 |
Track Aggressive Fibromatosis automatically
Every clearance here is in the API, with alerts when new ones post.